Answer
Safinamide increases extracellular dopamine levels in the striatum through highly selective, reversible inhibition of monoamine oxidase B (MAO-B).
Sources for this answer
- Safinamide 50 mg film-coated tabletsMSN Laboratories Europe Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked